Rheostat raises $23M to target the cell's garbage disposal by Amirah Al Idrus Monday, November 26, 2018 Rheostat Therapeutics raised $23 million to develop treatments for neurodegenerative and rare diseases by targeting the cell’s garbage disposal.
Mayo Clinic, Helix launch at-home DNA testing program by Conor Hale Monday, October 1, 2018 The Mayo Clinic and Helix launched a new personal genomics product aimed at providing healthy individuals with DNA testing focusing on education.
Mayo Clinic, OmniTier speed up de novo genome sequencing by Amirah Al Idrus Wednesday, August 15, 2018 Mayo Clinic and OmniTier have shown that de novo whole genome sequencing can be done without the need for “supercomputing-level resources."
Pinpointing genes that raise the risk of triple-negative breast cancer by Arlene Weintraub Monday, August 6, 2018 Researchers have discovered seven gene alterations that could improve surveillance for triple-negative breast cancer risk.
New discoveries in diabetes and pancreatic cancer—News of Note by Arlene Weintraub Monday, June 25, 2018 New discoveries in biotech include a coated capsule for delivering insulin and inherited gene mutations that may portend pancreatic cancer risk.
Exact Sciences’ blood panel detects 93% of early liver cancers by Conor Hale Tuesday, June 5, 2018 Exact Sciences and the Mayo Clinic developed a DNA-based blood panel that detects 95% of all stages of liver cancer and outperforms common serum tests.
Mayo Clinic, AliveCor use AI to spot ‘invisible’ heart condition by Conor Hale Friday, May 11, 2018 The Mayo Clinic and AliveCor showed how AI can identify increased risks of arrhythmias and sudden cardiac death despite a normal rhythm on an EKG.
Vineti bags $34M to support CAR-T logistics by Nick Paul Taylor Monday, April 16, 2018 The investment sets the Kite Pharma-partnered firm up to refine software to orchestrate the many steps involved in the production of cell therapies.
Monoclonal microbial startup Evelo files for $100M IPO by Nick Paul Taylor Monday, April 16, 2018 The IPO comes as the Flagship startup prepares to test its lead inflammatory disease and anticancer microbial strains in humans.
Anti-aging outfit Unity bags $55M and looks to the clinic by Amirah Al Idrus Tuesday, March 20, 2018 The new funding will propel Unity Biotechnology's osteoarthritis asset into its first clinical trial.
